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NKG2D Triggers Cytotoxicity in Murine Epidermal cd
T Cells via PI3K-Dependent, Syk/ZAP70-Independent
Signaling Pathway
Atsuko Ibusuki1, Kazuhiro Kawai1,2, Shigeru Yoshida3,4, Youhei Uchida1, Ayano Nitahara-Takeuchi5,
Kimiko Kuroki6, Mizuho Kajikawa7, Toyoyuki Ose6, Katsumi Maenaka6, Masanori Kasahara4 and
Takuro Kanekura1
Murine epidermal gd T cells, known as dendritic epidermal T cells (DETCs), survey tissue stress through the
invariant T-cell receptor (TCR) and non-clonotypic receptors such as NKG2D. NKG2D signaling via the DAP10-
phosphatidylinositol 3-kinase (PI3K) pathway directly stimulates cytotoxicity in natural killer (NK) cells and
costimulates CD8þ T cells to augment TCR signals. In activated murine NK cells, NKG2D signals also
via the DAP12-Syk/ZAP70 pathway that triggers both cytotoxicity and cytokine production. It remains controversial
whether NKG2D on DETCs is a primary activating receptor or functions only as a costimulatory receptor,
and signaling pathways initiated by NKG2D ligation in DETCs have not been analyzed. We show that
stimulation of short-term DETC lines with recombinant NKG2D ligands triggers degranulation (exocytosis of
cytotoxic granules) via the PI3K-dependent signaling pathway, but does not induce cytokine production or Syk/
ZAP70 activation. Coengagement of TCR or Syk/ZAP70 signaling was not crucial for DETC-mediated killing of
NKG2D ligand-expressing target cells. Thus, NKG2D can function as a coactivating stress receptor that directly
triggers cytotoxicity in DETCs, at least after priming, via the PI3K-dependent, Syk/ZAP70-independent signaling
pathway.
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INTRODUCTION
Most epithelial tissues contain resident T cells that express
tissue-specific invariant or restricted gd T-cell receptors (TCRs)
(Witherden and Havran, 2011). These epithelial gd T cells
mediate stress surveillance in the given tissue and exert various
effector and regulatory functions to maintain tissue integrity
(Hayday, 2009; Bonneville et al., 2010; Witherden and Havran,
2011). Dendritic epidermal T cells (DETCs) are prototypic
epithelial gd T cells that reside in the murine skin and express
a canonical Vg3Vd1 (nomenclature according to Garman et al.
(1986)) TCR (Witherden and Havran, 2011). DETCs secrete
growth factors, cytokines, and chemokines, and release
cytotoxic granules in response to tissue stress, and contribute
to wound healing (Jameson et al., 2002), epidermal homeostasis
(Sharp et al., 2005; Girardi et al., 2006), hair cycle regulation
(Kloepper et al., 2013), immunoregulation (Shiohara et al.,
1996; Girardi et al., 2002; Strid et al., 2011), and tumor
surveillance (Girardi et al., 2001; Strid et al., 2008).
DETCs recognize an as-yet-undetermined self ligand
induced on stressed, damaged, or transformed keratinocytes
through the invariant TCR (Havran et al., 1991; Tigelaar and
Lewis, 1994; Jameson et al., 2004). In situ immuno-
fluorescence staining with soluble DETC TCR tetramers
demonstrated that the DETC TCR ligand is undetectable in
the normal epidermis, but upregulated on periwound
keratinocytes rapidly and transiently after wounding (Komori
et al., 2012). Accumulating evidence suggests, however, that
low levels of the DETC TCR ligand, which might not be
detectable by immunofluorescence staining, are expressed on
healthy keratinocytes in vivo (Mallick-Wood et al., 1998;
Aono et al., 2000; Hara et al., 2000; Minagawa et al., 2001;
Jameson et al., 2004; Leandersson et al., 2006). Constitutive
expression of the DETC TCR ligand in the normal epidermis
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is supported by the recent observation using intravital
dynamics–immunosignal correlative microscopy that TCRs
on DETCs are clustered and triggered at steady state in
immunological synapse-like structures on the apical dendrites
located near the keratinocyte tight junctions (Chodaczek et al.,
2012). In response to tissue stress, these TCR-triggered
proximal signals are relocated from the apical dendrites
to the newly formed synapses, but whole-cell amount of
TCR signals does not increase (Chodaczek et al., 2012).
Therefore, stress-induced DETC activation would require
relocalization of the TCR–ligand interactions and/or
additional signals through non-TCR stress receptors such as
junctional adhesion molecule-like protein (JAML) (Witherden
et al., 2010), CD100 (Witherden et al., 2012), and NKG2D
(Jamieson et al., 2002).
NKG2D is a homodimeric C-type lectin–like receptor
expressed on natural killer (NK) cells, CD8þ T cells (only
after activation in mice), and subsets of CD4þ T cells (in
humans), NKT cells, and gd T cells (Raulet, 2003). NKG2D
recognizes a diverse family of major histocompatibility
complex class I–related proteins that are poorly expressed
on healthy cells, but upregulated on stressed, infected, or
transformed cells (Raulet, 2003; Champsaur and Lanier, 2010;
Raulet et al., 2013). NKG2D ligands (NKG2DLs) comprise
three members of the histocompatibility 60 family (H60a–c),
five members of the retinoic acid early inducible-1 family
(Rae-1a-e), and murine UL16-binding protein–like transcript 1
(MULT1) in mice, and major histocompatibility complex class
I chain–related proteins A (MICA) and B (MICB), and six
UL16-binding proteins (ULBP1–6) in humans (Champsaur and
Lanier, 2010; Raulet et al., 2013).
Functional outcome of NKG2D ligation varies depending
on the cell type and activation state. This is, at least in part,
explained by the differential usage of two transmembrane
adaptor proteins, DAP10 and DAP12, that associate with
NKG2D and transduce signals (Raulet, 2003; Lopez-Larrea
et al., 2008). In mice, alternative splicing generates two
functionally distinct NKG2D isoforms, NKG2D-L (long) and
NKG2D-S (short), that differ in the cytoplasmic domain and
associated signaling adaptors (Diefenbach et al., 2002).
NKG2D-L associates with DAP10, whereas NKG2D-S,
which is induced on murine NK cells after activation, can
associate with both DAP10 and DAP12 (Diefenbach et al.,
2002). Human NKG2D is an equivalent of murine NKG2D-L
and associates only with DAP10 (Wu et al., 1999, 2000;
Billadeau et al., 2003; Andre et al., 2004; Rosen et al., 2004).
DAP10 contains a YXNM motif (Wu et al., 1999) that recruits
the p85a subunit of phosphatidylinositol 3-kinase (PI3K)
(Wu et al., 1999; Billadeau et al., 2003; Upshaw et al.,
2006) as well as Grb2 and Vav1 (Billadeau et al., 2003; Cella
et al., 2004; Graham et al., 2006; Upshaw et al., 2006).
DAP12 contains an immunoreceptor tyrosine-based activation
motif (ITAM) that recruits Syk family protein tyrosine kinases,
Syk and ZAP70 (Lanier et al., 1998). NKG2D-DAP10-
mediated PI3K and Grb2-Vav1 signaling triggers cytotoxicity
in both murine and human NK cells, but is insufficient for
inducing cytokine production (Wu et al., 2000; Diefenbach
et al., 2002; Gilfillan et al., 2002; Billadeau et al., 2003;
Zompi et al., 2003; Cella et al., 2004; Graham et al., 2006;
Upshaw et al., 2006). By contrast, NKG2D-S-DAP12-
mediated Syk/ZAP70 signaling triggers both cytotoxicity and
cytokine production in activated murine NK cells (Diefenbach
et al., 2002; Gilfillan et al., 2002; Zompi et al., 2003).
As most T cells do not express DAP12, NKG2D signals
solely through DAP10 in murine as well as human CD8þ T
cells (Lanier et al., 1998; Diefenbach et al., 2002; Gilfillan
et al., 2002). Unlike NK cells, NKG2D engagement alone is
generally insufficient to activate CD8þ T cells, and provides
only costimulatory signals that augment TCR signals (Groh
et al., 2001; Roberts et al., 2001; Diefenbach et al., 2002;
Jamieson et al., 2002; Maasho et al., 2005) under restricted
conditions (Ehrlich et al., 2005; Rajasekaran et al., 2010).
DETCs can be activated simply by acute, keratino
cyte-specific upregulation of NKG2DLs (presumably without
upregulation of the DETC TCR ligand) in vivo (Strid et al.,
2008, 2011). Without NKG2DL recognition, promotion of
wound healing by DETCs is impaired (Jung et al., 2012;
Yoshida et al., 2012). NKG2D has also been implicated in
DETC-mediated tumor surveillance (Girardi et al., 2001;
Oppenheim et al., 2005; Strid et al., 2008). It has been
controversial, however, whether NKG2D directly stimulates
DETC activation or serves only as a costimulatory receptor
in DETCs. We reported previously that unlike most other T
cells, DETCs constitutively express both NKG2D-L and
NKG2D-S isoforms as well as DAP10 and DAP12 adaptors,
and NKG2D ligation alone is sufficient to trigger both cyto-
toxicity and cytokine production in DETCs in the absence of
TCR coengagement (Nitahara et al., 2006). Another group,
conversely, reported that NKG2D functions only as a costimu-
latory receptor in DETCs (Whang et al., 2009).
In this study, we reanalyzed the functional outcome of
NKG2D engagement in DETCs using recombinant NKG2DL
proteins, because different mAbs were used for NKG2D
crosslinking in the previous studies (Nitahara et al., 2006;
Whang et al., 2009). We show that NKG2D engagement with
NKG2DLs triggers degranulation via the PI3K-dependent
signaling pathway, but does not induce cytokine production
or Syk/ZAP70 activation in DETCs. Consistent with these data,
coengagement of TCR or Syk/ZAP70 signaling was not crucial
for DETC-mediated lysis of NKG2DL-expressing target cells.
RESULTS
Recombinant NKG2DL proteins stimulate degranulation but not
cytokine production in DETCs
Consequence of NKG2D ligation in DETCs was controversial
in the previous studies (Nitahara et al., 2006; Whang et al.,
2009). We confirmed that this was caused by the difference in
the mAbs used for NKG2D crosslinking (Supplementary Text 1
and Supplementary Figure S1 online). To analyze the func-
tional outcome of NKG2D ligation in DETCs in a more
physiological setting, we stimulated DETCs with recombinant
NKG2DL proteins instead of anti-NKG2D mAbs. Stimulation
of DETCs with plate-bound H60a-Fc, Rae-1d-Fc, and
Rae-1e-Fc fusion proteins induced degranulation (Figure 1a)
but virtually no IFN-g, tumor necrosis factor a, or IL-13
production (Figure 1b and data not shown). The degranulation
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responses were completely blocked with soluble anti-NKG2D
mAb (Supplementary Figure S2 online).
H60c is an NKG2DL that is predominantly expressed in the
skin (Takada et al., 2008; Whang et al., 2009; Yoshida et al.,
2012) and upregulated on stressed or damaged keratinocytes
(Whang et al., 2009; Yoshida et al., 2012). As spontaneously
formed recombinant H60c (rH60c) dimers bind to NKG2D
with very low affinity (Yoshida et al., 2012), the monomeric
form of the recombinant extracellular domain protein,
rH60c C150S, was used for DETC stimulation. Similar
to the NKG2DL-Fc fusion proteins, plate-bound rH60c
C150S induced degranulation (Figure 1c) but not IFN-g
production in DETCs (Figure 1d). The degranulation responses
to rH60c C150S were lower than those to NKG2DL-Fc fusion
proteins, but this would be due to the inefficient immobi-
lization or inappropriate dimensions of the recombinant
extracellular domain proteins of NKG2DL, because
rH60a also induced lower responses than H60a-Fc
(Figure 1a and c).
NKG2DL triggers degranulation in DETCs via the PI3K-
dependent, Syk/ZAP70-independent signaling pathway
In murine NK cells, either NKG2D-DAP10-mediated PI3K/
Grb2-Vav1 signaling or NKG2D-S-DAP12-mediated Syk/
ZAP70 signaling is sufficient to trigger cytotoxicity, but the
latter signaling pathway is crucial for cytokine production
(Diefenbach et al., 2002; Gilfillan et al., 2002; Zompi et al.,
2003). Induction of degranulation but not cytokine production
by NKG2D engagement with NKG2DLs (Figure 1) suggests
that NKG2DLs cannot trigger NKG2D-S-DAP12 signaling in
DETCs. As expected, stimulation of DETCs with H60a-Fc
rapidly induced PI3K-dependent phosphorylation of Akt,
which was confirmed by blocking with a PI3K-specific
inhibitor LY294002 (Figure 2a), but did not trigger phosphor-
ylation of Syk/ZAP70 (Figure 2b).
The degranulation responses of DETCs to H60a-Fc were
also blocked with the PI3K inhibitor in a dose-dependent
manner, whereas Syk/ZAP70-specific inhibitor piceatannol
showed modest blocking only at a high concentration
(50mM) owing to the off-target effects (Colucci et al., 2002)
(Figure 3). In contrast, IFN-g production in DETCs on stimula-
tion with the potent anti-NKG2D mAb (clone 191004) was
dose-dependently attenuated with the Syk/ZAP70 inhibitor
(Figure 3).
TCR signaling is not necessary for DETC-mediated killing of
NKG2DL-expressing target cells
We next determined whether DETCs can kill NKG2DL-
expressing target cells in the absence of TCR coengagement.
For this purpose, we used H60a- and H60c-transduced Ba/F3
cells and primary cultured keratinocytes from TCRd / mice
on a C57BL/6 background as targets cells for the cytotoxicity
assay. Mock-transduced Ba/F3 cells that expressed only low
levels of MULT1 but not other NKG2DLs or the DETC TCR
ligand (Supplementary Figure S3 online) were not killed by
DETCs (Figure 4a). Expression of either H60a or H60c alone,
without induction of other NKG2DLs or the DETC TCR ligand
(Supplementary Figure S3 online), was sufficient to convert
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Figure 1. Recombinant NKG2D ligand (NKG2DL) proteins stimulate
degranulation but not cytokine production in dendritic epidermal T cells
(DETCs). (a, b) DETCs were stimulated with indicated NKG2DL-Fc or
control-Fc, and (a) degranulation (cell surface CD107a expression) and
(b) intracellular IFN-g production were analyzed by flow cytometry. (c, d)
DETCs were stimulated with indicated recombinant extracellular domain
proteins of NKG2DL (rNKG2DL) or control protein (BSA), and (c)
degranulation and (d) intracellular IFN-g production were analyzed by flow
cytometry. Data are expressed as mean positive cells (%) and SD.
Representative data from three independent experiments are shown.
Significant differences as compared with control are denoted with asterisks
(*Po0.05, **Po0.01, ***Po0.001).
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Ba/F3 cells to susceptible target cells for DETC-mediated
killing, and the lysis was completely blocked with anti-
NKG2D mAb (Figure 4a). DETC-mediated killing of the
H60c-Ba/F3 cells was also blocked with anti-H60c mAb but
not with anti-TCR mAb (Figure 4b).
Consistent with the previous report (Whang et al., 2009),
H60c but not other NKG2DLs was induced on cultured
keratinocytes (H60a protein cannot be expressed in the
C57BL/6 background and H60b is not expressed on keratino-
cytes; Takada et al., 2008; Whang et al., 2009; Yoshida et al.,
2012) (Supplementary Figure S3 online). We also confirmed
expression of the DETC TCR ligand on cultured keratinocytes
using the soluble DETC TCR (Supplementary Figure S3
online). DETCs could efficiently kill cultured keratinocytes
(Figure 5), but in contrast to the absolute dependence on
NKG2D in the lysis of NKG2DL-transduced Ba/F3 cells
(Figure 4), the lysis of keratinocytes by DETCs was blocked
only partially with the anti-NKG2D mAb (Figure 5). Complete
inhibition of DETC-mediated killing of keratinocytes with
another anti-NKG2D mAb (clone MI6) was reported pre-
viously (Whang et al., 2009), but we found that the mAb
MI6 inhibited the lysis less efficiently than the blocking mAb
191004 used in this study (data not shown). The DETC-
mediated lysis of keratinocytes was also partially blocked
with anti-CD3 and anti-TCR mAbs (Figure 5), and additive
blockade was observed in the presence of both anti-NKG2D
and anti-TCR/CD3 mAbs (Figure 5b). Thus, DETC-mediated
killing of stressed keratinocytes can occur in the absence of
either NKG2D or TCR ligation, indicating that both receptors
act as independent coactivating receptors in DETCs.
As expected, the lysis of keratinocytes by DETCs was
completely abolished with the PI3K inhibitor (Figure 6). In
contrast, inhibition of Syk/ZAP70 only partially blocked the
lysis (Figure 6).
DISCUSSION
We showed that NKG2D engagement with NKG2DLs alone is
sufficient to trigger degranulation but not cytokine production
in DETCs. Contrary to our earlier conclusion (Nitahara et al.,
2006), NKG2DL-triggered DETC activation is mediated via the
PI3K-dependent signaling pathway, but not via the NKG2D-S-
DAP12-Syk/ZAP70 pathway. Although DETCs constitutively
express NKG2D-S and DAP12 transcripts (Nitahara et al.,
2006) and can secrete IFN-g when stimulated with some
potent anti-NKG2D mAbs (Nitahara et al. (2006) and Supple-
mentary Figure S1b online), NKG2DLs may not be able to
engage enough NKG2D-S-DAP12 receptor complexes, which
might be fewer than NKG2D-DAP10 on DETCs, to trigger Syk/
ZAP70 signaling.
We also showed that DETCs can kill NKG2DL-transduced
Ba/F3 target cells that do not express the TCR ligand. Our
results that DETCs cannot kill mock-transduced Ba/F3 cells
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Figure 2. NKG2D ligand (NKG2DL) triggers phosphatidylinosital 3-kinase (PI3K) but not Syk/ZAP70 signaling in dendritic epidermal T cells (DETCs). DETCs
were preincubated with DMSO or 10mM LY294002, and stimulated with H60a-Fc or hydrogen peroxide (H2O2) (positive control for Syk/ZAP70 phosphorylation;
Schieven et al., 1994; Haas et al., 2008). Intracellular expression levels of (a) phosphorylated Akt and (b) Syk/ZAP70 were analyzed by flow cytometry. Fold
change in mean fluorescence intensity (MFI) was determined as geometric MFI at indicated time point/geometric MFI before stimulation. Data are expressed as
mean fold change and SD. Significant increases in the phosphorylation on stimulation are denoted with asterisks (**Po0.01, ***Po0.001). Representative
profiles at 5 minutes (open histograms) from three independent experiments are also shown. Shaded histograms indicate cells before stimulation.
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and that DETC-mediated lysis of NKG2DL-transduced Ba/F3
cells is completely blocked with anti-NKG2D and anti-H60
mAbs, but not with anti-TCR mAb, indicate that NKG2D can
act as a primary activating receptor in DETC-mediated killing
of NKG2DL-expressing target cells. In contrast to our results, a
previous study demonstrated that DETCs cannot kill the Fc
receptor–bearing human B cell lymphoma Daudi cells or
murine mastocytoma P815 cells coated with anti-NKG2D
mAb (Whang et al., 2009), but this could be expected because
the ‘‘non-stimulating’’ anti-NKG2D mAb (clone MI6) was
used for the redirected cytotoxicity assay. It was also
reported that DETCs cannot kill H60c-transduced Daudi
cells (Whang et al., 2009). The basis of this discrepancy is
unknown, but the levels of H60c expression on H60c-
transduced Daudi cells might be low to trigger NKG2D
signaling in DETCs. Alternatively, murine Ba/F3 cells, but
not human Daudi cells, might express ligands for additional
receptors on DETCs that augment NKG2D signals to induce
cytotoxicity. In this case, NKG2D functions as a synergistic
coactivating receptor rather than the primary activating
receptor. Nevertheless, TCR-independent stimulation of
DETC cytotoxicity through NKG2D is distinct from the
classical costimulation in conventional CD8þ T cells, for
which TCR signaling is crucial.
Partial blocking of the DETC-mediated lysis of keratinocytes
with both anti-NKG2D and anti-TCR mAbs is consistent with
the previous study using the PDV-transformed keratinocyte
cell line as target cells (Girardi et al., 2001) and with our prior
observation that DETC-mediated lysis of the Pam 212–
transformed keratinocyte cell line, which expresses the DETC
TCR ligand but only low levels of H60, is completely inhibited
with anti-TCR mAb alone (Nitahara et al. (2006), Ito et al.
(2008), and unpublished data). Contrary to these results, a
previous study demonstrated that DETC-mediated killing
of keratinocytes was absolutely dependent on NKG2D
(Whang et al., 2009). In that study, however, the lysis of
keratinocytes by DETCs was generally low as compared with
that observed in our study (Whang et al., 2009), suggesting
that some additional coactivating/costimulatory receptors
other than NKG2D might be lost during preparation of
DETCs. Involvement of additional receptor–ligand interactions
in the DETC-mediated lysis of keratinocytes is also supported
by the residual cytotoxicity in the presence of both anti-
NKG2D and anti-TCR mAbs (Figure 5b). DETCs may recog-
nize keratinocytes through a set of receptors including
NKG2D and TCR that bind to stress-induced as well as
constitutively expressed ligands, and these receptors may
act as synergistic coactivating/costimulatory receptors to
induce cytotoxicity.
Syk/ZAP70 act upstream of PI3K (Jiang et al., 2002; Lopez-
Larrea et al., 2008) and are crucial not only for NKG2D-S-
DAP12 signaling but also for TCR proximal signaling (Raulet,
2003; Lopez-Larrea et al., 2008). As DETC-mediated lysis of
keratinocytes is completely abolished with the PI3K inhibitor,
but only partially blocked with the Syk/ZAP70 inhibitor,
NKG2D-DAP10 signaling via the PI3K/Grb2-Vav1 pathway
alone is sufficient to trigger cytotoxicity against keratinocytes
in DETCs in the absence of both NKG2D-S-DAP12 and TCR
signals.
As we used short-term DETC lines that had been stimulated
through TCR and expanded in the presence of IL-2, the TCR-
independent promiscuous cytotoxicity through NKG2D might
be induced during in vitro culture (Supplementary Text 2
online). In fact, NKG2D cannot trigger cytotoxicity in freshly
isolated, purified DETCs ex vivo or after in vitro culture for
24 hours in the presence of IL-15, which upregulates NKG2D
expression (Roberts et al., 2001) and primes NKG2D-DAP10
signaling to induce cytotoxicity (Horng et al., 2007)
(unpublished data). In general, however, freshly isolated
DETCs do not exhibit cytotoxicity ex vivo, and their
acquisition of cytotoxicity requires 10–14 days of in vitro
culture in the presence of IL-2 (Nixon-Fulton et al., 1988;
Kaminski et al., 1993). Therefore, DETCs may have to be
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Figure 3. NKG2D ligand (NKG2DL) triggers degranulation in dendritic
epidermal T cells (DETCs) via the phosphatidylinositol 3-kinase (PI3K)–
dependent, Syk/ZAP70-independent signaling pathway. DETCs were
preincubated with indicated concentrations of LY294002 or piceatannol, and
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preactivated and/or primed with IL-2/IL-15 to exert
cytotoxicity through activating receptors including but not
limited to NKG2D. Once primed, however, DETCs can mount
cytotoxicity only by recognizing stress ligands through
NKG2D and/or other non-TCR receptors in the absence
of TCR engagement. Priming of DETCs may occur under
some conditions in vivo, as suggested by our observation
in vivo (Supplementary Text 3 and Supplementary Figure S4
online).
In summary, we have demonstrated that NKG2D-mediated
recognition of stress ligands is sufficient to trigger DETC
cytotoxicity via the PI3K-dependent, Syk/ZAP70-independent
signaling pathway, at least under restricted conditions.
Unlike the classical two-signal model in conventional T cells,
DETC activation may not always require simultaneous
coengagement of TCR and rather is regulated by the balance
between positive and negative signals provided through
various coactivating, costimulatory, and coinhibitory recep-
tors. Expression of multiple independent stress receptors such
as NKG2D would be beneficial for DETCs not only to mount
rapid, innate-like responses to tissue stress but also to avoid
inappropriate activation by accidentally expressed stress
ligands (Supplementary Text 4 online).
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MATERIALS AND METHODS
Cells
Short-term DETC lines from C57BL/6J mice were generated in each
experiment as described previously (Uchida et al., 2011). Ba/F3 cells
expressing H60a (H60a-Ba/F3) and H60c (H60c-Ba/F3) were
generated as described (Takada et al., 2008). Epidermal
keratinocytes from TCRd / mice on a C57BL/6 background were
cultured for 10 days as described (Yano and Okochi, 2005).
Stimulation assay
Fusion proteins of the extracellular domain of NKG2DL (H60a, Rae-
1d, or Rae-1e) and the Fc region of human IgG1 (NKG2DL-Fc) and
control human IgG1-Fc protein (control-Fc) were purchased from
R&D Systems (Minneapolis, MN). Recombinant extracellular domain
proteins of NKG2DL were produced in Escherichia coli as described
previously (Takada et al., 2008; Yoshida et al., 2012). In the rH60c
protein, the cysteine residue at position 150 was substituted with
serine (rH60c C150S) to prevent dimer formation (Yoshida et al.,
2012).
For stimulation assays, 96-well plates were coated overnight at 4 1C
with indicated concentrations of NKG2DL-Fc or control-Fc, or
recombinant extracellular domain proteins of NKG2DL or BSA
(Invitrogen, Carlsbad, CA) as control protein. DETCs (1 105) were
stimulated for 4 hours on the plates, and degranulation and intracel-
lular cytokine production were analyzed by flow cytometry as
described (Uchida et al., 2011). In some experiments, DETCs were
preincubated for 15 minutes at 4 1C with the predetermined saturating
concentration (50mg ml 1) of blocking anti-NKG2D (clone 191004;
R&D Systems) or isotype control mAb (eBioscience, San Diego, CA), or
for 30 minutes at 37 1C with indicated concentrations of LY294002
(Cell Signaling Technology, Danvers, MA), piceatannol (Sigma-
Aldrich, St Louis, MO), or DMSO as vehicle control before stimulation.
Intracellular phospho-flow cytometry
DETCs were preincubated for 30 minutes at 37 1C with 10mM
LY294002 or DMSO before stimulation with H60a-Fc or 10 mM
H2O2 (Schieven et al., 1994; Haas et al., 2008). To crosslink H60a-
Fc, DETCs incubated for 20 minutes on ice with 10mg ml 1 H60a-Fc
were further incubated for 20 minutes with 10mg ml 1 F(ab’)2 goat
anti-human Fcg antibody (Jackson ImmunoResearch, West Grove,
PA) before being transferred to a 37 1C water bath. At indicated time
points, stimulated cells were fixed for 10 minutes at 37 1C with 2%
paraformaldehyde (BD Cytofix Fixation Buffer; BD Biosciences, San
Jose, CA) and permeabilized for 30 minutes on ice with 90%
methanol (BD Phosflow Perm Buffer III; BD Biosciences). After prein-
cubation with anti-CD16/CD32 mAb (2.4G2; BD Biosciences), cells
were stained with phycoerythrin-conjugated anti-phosphorylated
Akt (Ser473) mAb (M89-61; BD Biosciences) or unlabeled rabbit
anti-phosphorylated Syk (Tyr352)/ZAP70 (Tyr319) antibody (Cell
Signaling Technology), followed by phycoerythrin-conjugated
F(ab’)2 donkey anti-rabbit IgG antibody (eBioscience). Expression
levels of the intracellular phosphoproteins were determined by flow
cytometry.
Cytotoxicity assay
DETCs and target cells were coincubated for 4 hours, and specific
lysis was determined as described (Uchida et al., 2011). Where
stated, effector cells were preincubated for 15 minutes at 4 1C with
50mg ml 1 of blocking anti-NKG2D (clone 191004) or isotype
control mAb and/or the predetermined saturating concentration
(1mg ml 1) of Fab fragments of anti-TCR Cd (UC7-13D5; a gift
from G Matsuzaki, Molecular Microbiology Group, Department of
Tropical Infectious Diseases, Tropical Biosphere Research Center,
University of the Ryukyus, Okinawa, Japan) or anti-CD3 (KT3;
prepared in our laboratory) mAb, or for 30 minutes at 37 1C with
indicated concentrations of LY294002, piceatannol, or DMSO before
addition to the target cells. Blocking with anti-H60c mAb (clone 5G6)
was performed as described (Yoshida et al., 2012).
Further information about other materials and methods used in this
study is provided in the Supplementary Material online.
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